Please assess the completion status of the following clinical trial:

Trial Title: Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* History of pancreatitis~* Medically stable~* Able to give informed consent~Exclusion Criteria:~* Prior history of pancreatic resection~* Prior history of pancreatic duct drainage procedure~* Presence of a pancreatic stent~* Unstable cardiovascular disease~* Any contraindication to MRI procedure~* Pregnancy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).